Clioquinol

氯碘羟喹

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameClioquinol
Drug Alias Name氯碘喹啉IodochlorhydroxyquinolineIodochlorhydroxyquin氯碘羟喹Chloroiodoquine +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesOtitis ExternaMultiple Myeloma +[10] 
Global Approved IndicationsMycosesBacterial Infections
Approved Indications in ChinaMycosesBacterial Infections
Original Approved Country/TerritoryMainland China
Original Approved Date1987/01/01
Country/TerritoryCanadaMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Tianyao Pharmaceutical Co Ltd
Inactive CompaniesUniversity Health Network (Uhn)
Active IndicationsMycosesBacterial Infections
Inactive IndicationsMyelodysplastic SyndromesOtitis ExternaMultiple Myeloma +[8] 

Other Information

ATC CodeD08AH30D09AA10G01AC02 +[5] 
Related LinksWikipediaDrugBankKEGG